Skip to main content

Table 1 Patient characteristics

From: Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

Characteristic

EG(n = 119)

CG(n = 98)

p -value

Histology

0.840

 Squamous

109

89

 

 Adenocarcinoma

10

9

 

Median age, y (range)

54(35–78)

54(32–78)

0.428

Chemotherapy

  

0.394

 Paclitaxel + Cisplatin

108

92

 

 Paclitaxel + Carboplatin

11

6

 

FIGO stage

  

0.229

 IIb

36

20

 

 IIIb

13

14

 

 IIIc1

54

42

 

 IIIc2

9

15

 

 IVa

7

7

 

Maximum tumor diameter (cm)

4.42 ± 0.94

4.51 ± 1.56

0.636

Pretreatment hemoglobin (g/L)

114.59 ± 17.10

112.87 ± 16.34

0.452

  1. EG The experimental group, CG The control group